RB1 and breast carcinoma: Estrogen binding to the ER initiates cyclin D transcription, followed by activation of the CDK4/6-RB1 pathway.360–362 Hence, dysregulation of the CDK4/6-RB1 pathway is a significant feature of hormone receptor (HR)-positive breast cancers.363